title: Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity.
abstract: Retroviruses establish productive infection only in proliferating cells. Macrophages are often considered to be non-proliferating in vitro yet are susceptible to HIV-1 infection. This has led to the conclusion that HIV-1 can establish infection independent of host cell proliferation. We here report that a small proportion of macrophages does have proliferative capacity. A comparable small fraction of monocyte derived macrophages (MDM) supported productive HIV-1 infection as demonstrated in limiting dilution culture. Fluorescence activated cell sorting on the basis of incorporation of BrdUrd, a thymidine analog, and subsequent PCR analysis revealed the presence of proviral DNA only in the BrdUrd positive cell fraction with DNA synthesizing activity. To identify which phase of cell cycle is required for establishment of productive infection, growth arrest in G1 or G1/S phase prior to inoculation was performed. gamma-Irradiation, which arrests primary cells in G1, prevented both cell proliferation and establishment of productive infection in MDM. Treatment of MDM with aphidicolin, a specific inhibitor of DNA polymerase alpha and delta which arrests cells in G1/S phase of the cell cycle, also inhibited DNA synthesis but did not prevent establishment of productive infection which is completely analogous to observations in T cells. Our data thus indicate that not cell division itself but cellular conditions that coincide with cell proliferation are apparently indispensable for establishment of productive infection.
authors.affiliation: Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
authors.forename: H
authors.initials: H
authors.lastname: Schuitemaker
authors.forename: N A
authors.initials: NA
authors.lastname: Kootstra
authors.forename: R A
authors.initials: RA
authors.lastname: Fouchier
authors.forename: B
authors.initials: B
authors.lastname: Hooibrink
authors.forename: F
authors.initials: F
authors.lastname: Miedema
mesh_terms: D016590:Aphidicolin / Q000494:pharmacology; D001483:Base Sequence; D002453:Cell Cycle; D002478:Cells, Cultured; D004279:DNA, Viral / Q000032:analysis; D005434:Flow Cytometry; D016193:G1 Phase; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000254:growth & development*; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000821:virology*; D008969:Molecular Sequence Data; D009000:Monocytes / Q000187:drug effects / Q000821:virology*; D019384:Nucleic Acid Synthesis Inhibitors; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000235:genetics; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D016196:S Phase; D013936:Thymidine / Q000031:analogs & derivatives; D014158:Transcription, Genetic
chemical_list: D004279:DNA, Viral; D019384:Nucleic Acid Synthesis Inhibitors; D016590:Aphidicolin; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase; D013936:Thymidine